BOSTON–(BUSINESS WIRE)–Oct 18, 2023– AVS (Amplitude Vascular Systems, Inc), an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease with its PIVL™ therapy, announced today it will present data from its POWER PAD I clinical trial at the Transcatheter Cardiovascular Therapeutics (TCT) conference, the Cardiovascular…Read More
AVS to Present PULSE IVL Clinical Trial Data at 2023 TCT Conference
